Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Phastar logo — Bringing data to life

Phastar

Bringing data to life

Founded 2007 United Kingdom London, United Kingdom 387 employees Growth Biotechnology, Data Analytics +3

General Information

Company Name Phastar
Founded Year 2007
Location United Kingdom London, United Kingdom
Employees 387
Industries Biotechnology, Data Analytics, Life Sciences +2
Funding Stage Growth
Business Model B2B, SaaS, DaaS
Revenue Model Service Fee, Project Based, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Phastar. To contact Phastar, visit phastar.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Phastar compare?

A PDF of Phastar and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Phastar soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Phastar

Founded in 2007 and headquartered in the United Kingdom, Phastar stands out in the Biotechnology, Data Analytics, Life Sciences, Medical Devices, and Pharmaceutical sectors with its slogan, "Bringing data to life." It is an award-winning specialist biometrics and data science CRO that is highly trusted by leading pharma, biotech, and medical device companies globally.

What sets Phastar apart is its capacity to transform complex trial data into clear, actionable intelligence, thus expediting the drug development process. Leveraging cutting-edge technology, AI-enhanced analytics, and deep therapeutic expertise, the company accelerates regulatory approvals, ensures compliance with global standards, and reduces risk.

The firm's last investment event, a Growth Equity VC on January 1, 2021, drew interest from Charterhouse Capital Partners. This financial backing underscores investor confidence in its scalable, tailored solutions aimed at bringing life-changing therapies to market faster.

Business keywords: Biometrics CRO, Statistical Consulting, Clinical Trial Reporting, AI-Enhanced Analytics, Therapeutic Expertise, Risk Mitigation, FSP-Style Arrangements, Adaptive Study Design, Bayesian Analysis, Data Visualization, CDISC Standards

Services & Products

Biometrics Contract Research
Data Solutions for Clinical Trials
Biostatistical Programming
Data Management and Analysis
Innovative Data Solutions

Target Customers

Pharmaceutical Companies Biotechnology Firms Healthcare Researchers Clinical Trial Sponsors Regulatory Bodies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity VC Undisclosed 1
Charterhouse Capital Partners
Charterhouse Capital Partners
01 Jan 2021

Phastar Alternatives & Competitors

View All Alternatives
Phastar vs
Intelligencia AI
Intelligencia AI United States

Applying machine learning in drug development

Series A
112 employees
AI, Big Data
Compare Phastar vs Intelligencia AI
Phastar vs
Massive Bio
Massive Bio Turkey

AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the onc...

Series B
103 employees
AI, Big Data
Compare Phastar vs Massive Bio
Phastar vs
Resolutum Global Pty Ltd
Resolutum Global Pty Ltd Australia

A boutique CRO that simplifies data collection, data management, statistical analysis and reporting...

19 employees
Biotechnology, Data Analytics
View all alternatives

FAQ About Phastar

Bringing data to life
Phastar was founded in 2007.
Phastar is headquartered in London, United Kingdom.
Phastar operates in Biotechnology, Data Analytics, Life Sciences, Medical Devices and Pharmaceutical. Its work centres on Biometrics CRO, Statistical Consulting, Clinical Trial Reporting and AI-Enhanced Analytics. Its customers include Pharmaceutical Companies, Biotechnology Firms and Healthcare Researchers.
Phastar has a B2B, SaaS and DaaS business model. Its revenue comes from Service Fee, Project Based and Consulting Fee.
Phastar has approximately 387 employees.
Phastar has completed 1 funding round. The latest funding stage is Growth.
Phastar offers: Biometrics Contract Research, Data Solutions for Clinical Trials, Biostatistical Programming, Data Management and Analysis, Innovative Data Solutions.
Top alternatives and competitors to Phastar include Intelligencia AI, Massive Bio, Resolutum Global Pty Ltd, uniQure, MindWalk Corp. (formerly BioStrand). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Phastar and Intelligencia AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Phastar, https://bouncewatch.com/company/phastar, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes